The CRISPR Patent Decision Didn’t Get the Science Right. That Doesn’t Mean It Was Wrong

September 13, 2018

(STAT News) – Many scientists disagree with the decision, believing that it fails to comport with how molecular biology is actually practiced. I agree with them. But that doesn’t make the Federal Circuit’s decision wrong. In fact, I think its decision is absolutely correct. The reason has to do with standards of review — the standards courts use to weigh evidence, limit their authority, and make decisions. Like criminal law’s “beyond a reasonable doubt” standard, standards of review are incredibly important for many legal cases. They’re how much one side needs to prove something and, failing that, who should win.

Posted by

Posted in Genetic Ethics, News, Op-Ed

Recommended Reading